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A non-cell autonomous mouse 
model of CNS haemangioblastoma 
mediated by mutant KRAS
Leyuan Bao1,*,†, Osama Al-Assar1,*, Lesley F. Drynan2, Mark J. Arends3, Pam Tyers4, 
Roger A. Barker4 & Terence H. Rabbitts1
Haemangioblastoma is a rare malignancy of the CNS where vascular proliferation causes lesions due 
to endothelial propagation. We found that conditionally expressing mutant Kras, using Rag1-Cre, gave 
rise to CNS haemangioblastoma in the cortex and cerebellum in mice that present with highly vascular 
tumours with stromal cells similar to human haemangioblastomas. The aberrant haemangioblastoma 
endothelial cells do not express mutant Kras but rather the mutant oncogene is expressed in CNS 
interstitial cells, including neuronal cells and progeny. This demonstrates a non-cell autonomous 
origin of this disease that is unexpectedly induced via Rag1-Cre expression in CNS interstitial cells. 
This is the first time that mutant RAS has been shown to stimulate non-cell autonomous proliferation 
in malignancy and suggests that mutant RAS can control endothelial cell proliferation in neo-
vascularisation when expressed in certain cells.
Mouse models of human cancer allow for a better understanding of the cell of origin, the disease process and for 
therapeutic testing. Many different brain tumours are found in humans of which about 1% are haemangioblasto-
mas that are slow growing and are non-invasive caused by vascular endothelium expansion within brain tissue1. 
They can be found in the brain stem, cerebellum (the most common form) and in the cerebrum and associated 
with von Hippel Lindau syndrome2 where it presents in a more malignant form.
There are currently no mouse models of haemangioblastoma in the CNS. We discovered a mouse model of 
haemangioblastoma in which endothelial cell proliferation occurs to cause deleterious lesions in the brain when 
we implemented activation of a conditional form of floxed mutant Kirsten Ras (KRas) with glycine 12 mutation to 
valine (KRasG12V)3 using the VDJ recombinase activating gene 1 (Rag1) to express Cre recombinase4. This was 
unexpected since the conditional KRas allele was activated by Rag1-Cre expressed in the brain and because the 
endothelial cells involved do not themselves express the mutant allele of KRas, signifying a non-cell autonomous 
proliferation causing this disease.
Materials and Methods
Mouse strains and haemangioblastoma pathology. Floxed KRasG12V mice3 were crossed with Rag1-
Cre knock in mice4 to generate mice carrying both alleles. When abnormal phenotypes developed, mice were 
sacrificed by terminal anaesthesia and perfusion fixation. Whole brains were dissected carefully and fixed in 
4% paraformaldehyde for 24 hours and equilibrated in 20% sucrose in PBS-0.1%azide at 4 oC overnight. 20 uM 
sections were prepared on a freezing microtome and stained either with cresyl violet or haematoxylin and 
Immunohistochemistry carried out with anti-CD31 at 1/20 dilution of rabbit anti-CD31 (Abcam-ab28364) with 
citric acid antigen retrieval method. All experiments with mice were conducted under a Home Office Personal 
License and with agreement from the University of Oxford Animal Welfare and Ethical Review Committee.
Reporter gene expression analysis. Rag1-Cre mice were bred with ROSA-tdTomato reporter mice5 and 
30 day old heterozygous pups were perfusion fixed with 50 mL 10% buffered formalin after clearing the blood 
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with 50 mL of ice cold PBS supplemented with 1 mM EDTA and the brain removed. Post- dissected whole brains 
were fixed in ice cold 10% buffered formalin for one hour and submerged in 25% sucrose/PBS overnight. Brains 
were mounted in tissue freezing medium (Fisher Scientific) and snap frozen on dry ice assisted by freezing aerosol 
(VWR). Sections were subsequently cut using a Leica cryostat system at 10 μ m thickness and allowed to adhere 
to Superfrost Plus slides (Fisher Scientific) at 37 °C for one hour. Sections were stored for short term at 4 °C 
before further processing. For microscopy, sections were first mounted in ProLong Gold containing DAPI (Life 
Technologies) before being viewed using a Zeiss LSM 880 system. Images were captured using tile-scanning at 
25x magnification or no tile-scanning at 40x magnification.
Laser capture microdissection (LCM). LCM was performed using a Zeiss PALM MicroBeam system. 
Diseased transgenic brains were processed as for pathology and then mounted on special MembraneSlide (Zeiss) 
slides at a thickness of 7 μ m. Before LCM capturing, the slides were de-paraffinised using HistoClear II solution 
(VWR) twice for 5 minutes each. The slides were allowed to dry completely after dehydration in 100% etha-
nol twice for 10 minutes each. Different areas of interest were captured in special AdhesiveCap tubes (Zeiss). 
Extraction of genomic DNA was carried with using a QIAamp DNA FFPE Tissue Kit (Qiagen) according to man-
ufacturer’s instructions. For PCR of the recombined (AG2 band) and non-recombined (GFP band) transgene, a 
previously described method was used1. High fidelity amplified bands (Q5 polymerase, NEB) were cut from an 
agarose gel and purified using Qiagen MinElute kit and cloned into Zero-Blunt TOPO vector (Life Technologies) 
before transformation into chemically competent DH5α E.coli. Three individual clones were selected from 
Kanamycin plates for each of the AG2 and GFP bands and sequenced using SP6, M13 or T7 primers in the for-
ward and reverse directions. Relevant sequences are shown in Supplementary Fig. 1. Alignment of the sequenced 
bands with the reference sequence was done using BLAST at NIH.
Results
We discovered a mouse model of haemangioblastoma caused by activation of a conditional form of floxed mutant 
Kirsten Ras (KRas) with glycine 12 mutation to valine (KRasG12V)3 using the VDJ recombinase activating gene 
1 (Rag1) to express Cre recombinase4. Unexpectedly, we observed that the majority of the mice carrying both the 
floxed KRasG12V gene and the Rag1-Cre (Fig. 1A) developed an abnormal gait and light sensitivity within two 
months and post-mortem examination revealed hydrocephalus and CNS vascular proliferations with features of 
haemangioblastoma. The typical phenotypic features were a tendency to be off balance, moving in circles, unsta-
ble gate and sensitivity to light. The brains of these animals showed signs of widespread haemorrhage, predomi-
nantly in the cerebrum (Fig. 1B,C).
Interbreeding a mouse strain carrying a conditional allele of KRASG12V with a Rag1-Cre strain gave rise to 
double transgenic mice that developed an abnormal gait in ~80% of individuals with a mean onset at 40 days 
(Fig. 1D). Histologically the brains show vascular tumours (Fig. 1E,F) that have histopathological features typical 
of human CNS haemangioblastoma., including variable and irregularly sized blood vessel channels and pseudo-
cystic spaces, lined by endothelial cells with pleomorphic nuclei, with accompanying stromal cells. The mouse 
model CNS tumour lesions showed a close juxtaposition of endothelial lined capillaries type vessels and stromal 
cells. The stromal cells often had a pink vacuolated appearance indicative of lipid accumulation, but no stromal 
cell mitotic figures were seen. The vascular channel lining cells were immunostained positively with anti-mouse 
CD31 antibody (Fig. 1G,H) confirming detection of endothelial cells forming irregular vascular channels and 
pseudocystic spaces, (with negatively staining interstitial vacuolated stromal cells), characteristic of haemangio-
blastomas. The tumours expand and infiltrate into the surrounding brain tissue with destructive effects, resulting 
in adverse brain functions.
As Rag1 expression is not associated with blood vessel endothelium, we sought evidence of the Cre-activated 
KrasG12V in isolated endothelial cells using laser capture microscopy (LCM). Endothelial layers from the hae-
mangioblastomas were marked in fixed sections (Fig. 2A) and dissected together with interstitial tissue (Fig. 2A,B 
shows before & after LCM). Genomic DNA was extracted and PCR carried out with primers that detect the floxed 
GFP gene and the deleted allele (i.e. activated Kras) following Cre-mediated deletion (and Gapdh as a control) 
(shown in Fig. 2C). Two separate gDNA LCM isolations were analysed (Fig. 2D), and in both we detected the 
activated Kras allele in the interstitial cells, but not the floxed allele, whereas the floxed allele was still present 
in the endothelial cells but not the activated Kras allele. This suggests that the endothelial proliferation is not 
cell-intrinsic but rather induced by cells in the surrounding tissue that have acquired activated Kras and presum-
ably secreting excitatory molecules.
Since the endothelial expansion is non-cell autonomous, other cells within the brain must be expressing the 
Rag1-Cre targeted allele. This was examined by employing a reporter mouse strain called ROSA-tdTomato that 
conditionally expresses the red fluorescent protein Tomato5. Rag1-Cre mice were crossed with ROSA-tdTomato 
mice, and post-mortem heterogeneous cell staining was found in sections of cerebellum and cerebrum of 
Rag1-Cre; ROSA-tdTomato double transgenic mice (Fig. 3A,B) but not ROSA-tdTomato-only mice (Fig. 3C,D). 
Spleens of Rag1-Cre; ROSA-tdTomato double transgenic mice as expected had abundant fluorescent cells 
(Fig. 3E,F). High power analysis of the cerebrum from the Rag1-Cre; ROSA-tdTomato double transgenic mouse 
indicated multiple cell types are present in the brain that express the Tomato reporter (Fig. 3G,H).
Discussion
The tumours observed in this mouse model represent the comparative pathological equivalent of human CNS 
haemangioblastomas with marked histological similarity displaying as highly vascular tumours with stromal cells 
similar to haemangioblastomas in humans. In a genome wide study of human angiosarcoma, RAS mutations (K, 
H or NRAS) were found in 5 out of 39 cases but other genes were considered to be aetiological6. In our model, 
we show using LCM that the Cre-dependent KrasG12V activation does not occur directly in endothelial cells 
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but rather in adjacent cells that express growth factors to drive vascular endothelial proliferation by a paracrine 
mechanism.
Although the exact identity of these cells is unknown, candidates are CNS cells that have Rag1 expression 
during development7. Cells in the brain that express the Rag-1 gene cause activation of the mutant Kras in this 
mouse model and that are responsible for the angiogenic effects we observe giving stimulus to the endothelial 
lesions. Astrocytes have been shown to secrete vascular endothelial growth factor (VEGF) in post-natal brains8,9 
and VEGF secretion can be stimulated in cells by activation of mutant KRAS10. Non-haematopoietic expression 
Figure 1. Incidence of haemangioblastoma in mice expressing mutant Kras. A cohort of double transgenic 
Rag1-Cre; KRasG12V floxed mice (n = 16) were monitored over a period of 120 days (Fig. 1A shows a diagram 
of Rag1-Cre allele4 and the flox-STOP KrasG12V allele3 is illustrated in Fig. 2C). Post-mortem was carried out 
on individual mice when signs of ill health were found. After sacrifice with fixation perfusion, whole mount 
brains are shown from 30 day Rag1-Cre; KRasG12V floxed mice (B) and wild type mice (C). A Kaplan-Meyer 
survival curve (D) reflects the incidence of disease. No abnormal phenotype was observed in Rag1-Cre mice or in 
KRasG12V floxed mice (n = 27) during the experimental period. Brains from affected mice were sectioned and 
stained with cresyl violet (E, x50; F, x400) or with haematoxylin (G, 4x; H, 10x). Sections were immunostained 
with rabbit anti-mouse CD31 antibody to detect endothelial cells forming irregular vascular channels and 
pseudocystic spaces, with some interstitial stromal cells, characteristic of haemangioblastomas (G, H).
www.nature.com/scientificreports/
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of Rag1 in brain cells remains controversial but our results support the hypothesis that Rag1 is important in 
brain function. Our work suggests a further study should be undertaken to establish the roles of Rag1 in brain 
Figure 2. Laser capture microscopy and genomic PCR from brain endothelial cells. The brain from a 
30 day old mouse with haemangioblastoma was fixed and sectioned for laser capture microscope recovery 
of endothelial lesion cells (2) and interstitial cells (3). Panel A and panel B show sections before and after 
LCM, respectively (1, intra-vascular cells). Genomic DNA was isolated from the cells and subjected to PCR 
amplification using the published PCR primers3 indicated in panel C. PCR products were separated on 1% 
agarose gels (panel D) using the PCR product of GAPDH as the control for captured DNA. Two independent 
analyses gave similar results. PCR products were cloned and sequenced; relevant sequences are shown in 
Supplementary Information Fig. 1. NB: the gels shown in panel D are cropped for illustration purposes and the 
originals are shown in Supplementary Information Fig. 2.
www.nature.com/scientificreports/
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Figure 3. Heterogeneity of tdTomato reporter gene expression in Rag1-Cre mouse brains. Rag1-Cre mice 
were crossed with ROSA-tdTomato5 reporter mice and perfusion fixed when 30 days old. Brains were dissected 
from Rag1-Cre; ROSA-tdTomato double positive and from ROSA-tdTomato-only mice. Sections were prepared 
and stained as described in the online methods. Confocal microscope tiled images showing red fluorescence 
or DAPI stain. Panels A, B; a Rag1-Cre; ROSA-tdTomato brain section. Panels C, D; a ROSA-tdTomato-only 
brain section. Panels E, F; Rag1-Cre; ROSA-tdTomato spleen section; Panels A, C and E are red fluorescent 
images overlaid on DAPI stain; panels B, D, F are DAPI-only images. Panels G, H; show the Rag1-Cre; ROSA-
tdTomato brain section from panel A at higher fluorescence intensity and the boxed region is shown at higher 
magnification (cerebrum) in panel H. Identical data were obtained from several technical and biological repeats 
from independent transgenic mating experiments. The size bars are 200 um (panels A–G) and 20 uM in panel H.
www.nature.com/scientificreports/
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biology and of VEGF-VEGFR interaction in CNS haemangioblastoma. The observation that mutant RAS express-
ing cells can induce endothelial cell proliferation also has important potential implications for angiogenesis in 
solid tumour growth where neo-vascularisation enhances tumour growth and supports dissemination of dis-
ease to create metastasis. In turn, the metastatic deposits, themselves carrying mutant RAS, could engender 
neo-vascularisation to sustain their own expansion.
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